Jessica Hartmann holds a PhD in Biochemistry and is currently Deputy Head of the Molecular Biotechnology and Gene Therapy group at the Paul-Ehrlich-Institut, Langen, Germany. Her research focuses on the development and engineering of cell type-selective gene transfer vectors, including lentiviral vectors, AAV and, more recently, LNPs. Her work contributes to various areas of gene therapy research, including cancer immunotherapy and neuroscience, with a current focus on developing targeted vectors for neuromuscular diseases.